Biofrontera(BFRI) - 2023 Q2 - Quarterly Report

OR Biofrontera Inc. (Exact name of registrant as specified in its charter) FORM 10-Q ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40943 (Mark One) For the quarterly period ended June 30, 2023 Delaware 47-3765675 (State or other jurisdiction of ...